Reckitt Benckiser Group (OTCMKTS:RBGLY) Raised to Buy at HSBC

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by research analysts at HSBC from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, MarketBeat.com reports.

RBGLY has been the subject of several other research reports. UBS Group upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Barclays raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. Finally, Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Reckitt Benckiser Group currently has an average rating of “Buy”.

Reckitt Benckiser Group Stock Performance

RBGLY opened at $12.24 on Wednesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $15.03. The company’s fifty day moving average price is $12.33 and its two-hundred day moving average price is $11.73.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.